Susquehanna International Group, LLP Becton Dickinson & CO Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $7.2 Million - $7.88 Million	32,500 Added 58.04%	88,500 $21.3 Million
Q2 2024 Aug 15, 2024	SELL	$225.07 - $246.17 $18.8 Million - $20.6 Million	-83,600 Reduced 59.89%	56,000 $13.1 Million
Q1 2024 May 07, 2024	SELL	$233.45 - $247.73 $34 Million - $36.1 Million	-145,600 Reduced 51.05%	139,600 $34.5 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $1.51 Million - $1.74 Million	-6,500 Reduced 2.23%	285,200 $69.5 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $8.16 Million - $9.07 Million	-32,000 Reduced 9.89%	291,700 $75.4 Million
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $9.11 Million - $10.1 Million	-38,200 Reduced 10.56%	323,700 $85.5 Million
Q1 2023 May 16, 2023	SELL	$229.71 - $259.35 $3.77 Million - $4.25 Million	-16,400 Reduced 4.34%	361,900 $89.6 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $11.3 Million - $13.3 Million	51,600 Added 15.79%	378,300 $96.2 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $2.32 Million - $12 Million	-45,500 Reduced 12.22%	326,700 $72.8 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $11.4 Million - $13.4 Million	48,600 Added 15.02%	372,200 $91.8 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $25.9 Million - $28.8 Million	-106,500 Reduced 24.76%	323,600 $86.1 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $34.9 Million - $38 Million	151,500 Added 54.38%	430,100 $108 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $90.5 Million - $99.7 Million	-388,800 Reduced 58.26%	278,600 $68.5 Million
Q2 2021 Aug 11, 2021	BUY	$232.65 - $254.58 $71.4 Million - $78.2 Million	307,100 Added 85.23%	667,400 $162 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $1.62 Million - $1.8 Million	7,000 Added 1.98%	360,300 $87.6 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $31.2 Million - $34.6 Million	140,600 Added 66.1%	353,300 $88.4 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $18.9 Million - $24.3 Million	-87,700 Reduced 29.19%	212,700 $49.5 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $7.81 Million - $9.35 Million	-35,500 Reduced 10.57%	300,400 $71.9 Million
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $22.2 Million - $31.6 Million	113,200 Added 50.83%	335,900 $77.2 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $14.2 Million - $16 Million	60,100 Added 36.96%	222,700 $60.6 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $4.4 Million - $4.89 Million	19,100 Added 13.31%	162,600 $41.1 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $3.89 Million - $4.4 Million	-17,900 Reduced 11.09%	143,500 $36.2 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $14.7 Million - $17.7 Million	71,500 Added 79.53%	161,400 $40.3 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $11.6 Million - $14.6 Million	-56,600 Reduced 38.63%	89,900 $20.3 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $139,842 - $153,600	-600 Reduced 0.41%	146,500 $38.2 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $12.2 Million - $13.7 Million	58,700 Added 66.4%	147,100 $35.2 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $5.16 Million - $6.03 Million	25,100 Added 39.65%	88,400 $19.2 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $6.54 Million - $7.7 Million	-34,600 Reduced 35.34%	63,300 $13.6 Million
Q3 2017 Nov 20, 2017	BUY	$186.89 - $198.9 $18.3 Million - $19.5 Million	97,900	97,900 $19.2 Million

Others Institutions Holding BDX

# of Institutions

1,735

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account